Brown spider (Loxosceles genus) venom toxins: Tools for biological purposes

Toxins

Volumn 3, Issue 3, 2011, Pages 309-344

  Chaim, Olga Meiri ^a   Trevisan Silva, Dilza ^a   Chaves Moreira, Daniele ^a   Wille, Ana Carolina M ^a,b   Ferrer, Valéria Pereira ^a   Matsubara, Fernando Hitomi ^a   Mangili, Oldemir Carlos ^c   da Silveira, Rafael Bertoni ^b   Gremski, Luiza Helena ^a   Gremski, Waldemiro ^a,d   Senff Ribeiro, Andrea ^a   Veiga, Silvio Sanches ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b STATE UNIVERSITY OF PONTA GROSSA   (Brazil)

^c INSTITUTO DE PESQUISA PELÉ PEQUENO PRÍNCIPE   (Brazil)

^d PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Biotechnological applications; Brown spider; Loxosceles; Recombinant toxins; Venom

Indexed keywords

APROTININ; ASTACIN; COMPLEMENTARY DNA; EXENDIN 4; HYALURONIDASE; INSECTICIDE; PHOSPHOLIPASE D; REAGENT; RECOMBINANT HYALURONIDASE; REGULATOR PROTEIN; SERINE PROTEINASE INHIBITOR; SPIDER VENOM; TISSUE PLASMINOGEN ACTIVATOR; TRANSCRIPTOME; TRANSLATIONALLY CONTROLLED TUMOR PROTEIN; UNCLASSIFIED DRUG; VINBLASTINE;

BIOASSAY; BIOTECHNOLOGICAL PRODUCTION; BRAIN ISCHEMIA; CHRONIC PAIN; CRYSTALLOGRAPHY; DNA LIBRARY; DRUG DELIVERY SYSTEM; ENZYME ASSAY; HUMAN; KAPOSI SARCOMA; MELANOMA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN FUNCTION; PROTEIN TARGETING; PROTEOMICS; REVIEW; SEQUENCE ALIGNMENT; SPIDER; TOXIN ANALYSIS; TOXIN STRUCTURE; TOXIN SYNTHESIS;

BIOTECHNOLOGICAL APPLICATIONS; BROWN SPIDER; LOXOSCELES; RECOMBINANT TOXINS; VENOM;

ANIMALS; BIOTECHNOLOGY; BROWN RECLUSE SPIDER; HYALURONOGLUCOSAMINIDASE; METALLOPROTEASES; PHOSPHOLIPASE D; SERINE PROTEINASE INHIBITORS; SPIDER VENOMS; TOXINS, BIOLOGICAL; TUMOR MARKERS, BIOLOGICAL;

ANIMALIA; ARANEAE; LOXOSCELES;

EID: 79953247952     PISSN: None     EISSN: 20726651     Source Type: Journal    
DOI: 10.3390/toxins3030309     Document Type: Review

References (226)

1. Binford, G.J., Bodner, M.R., Cordes, M.H., Baldwin, K.L., Rynerson, M.R., Burns, S.N., Zobel-Thropp, P.A. Molecular evolution, functional variation, and proposed nomenclature of the gene family that includes sphingomyelinase D in sicariid spider venoms. Mol. Biol. Evol. 2009, 26, 547-566.
2. Platnick N.I. The World Spider Catalog, Version. 9.0., American Museum of Natural History: New York, NY, USA, 2008,
3. Binford, G.J., Callahan, M.S., Bodner, M.R., Rynerson, M.R., Nunez, P.B., Ellison, C.E., Duncan, R.P. Phylogenetic relationships of Loxosceles and Sicarius spiders are consistent with Western Gondwanan vicariance. Mol. Phylogenet. Evol. 2008, 49, 538-553.
4. Appel, M.H., Bertoni da Silveira, R., Gremski, W., Veiga, S.S. Insights into brown spider and loxoscelism. Invertebr. Surviv. J. 2005, 2, 152-158.
5. Futrell J.M. Loxoscelism. Am. J. Med. Sci. 1992, 304, 261-267.
6. da Silva, P.H., da Silveira, R.B., Appel, M.H., Mangili, O.C., Gremski, W., Veiga, S.S. Brown spiders and loxoscelism. Toxicon 2004, 44, 693-709.
7. Hogan, C.J., Barbaro, K.C., Winkel, K. Loxoscelism: old obstacles, new directions. Ann. Emerg. Med. 2004, 44, 608-624.
8. Swanson, D.L., Vetter, R.S. Loxoscelism. Clinics. Dermatol. 2006, 24, 213-221.
9. Lung J.M., Mallory S.B. A child with spider bite and glomerulonephritis: A diagnostic challenge. Int. J. Dermatol. 2000, 39, 287-289.
10. Sales, P.B., Santoro, M.L. Nucleotidase and DNase activities in Brazilian snake venoms. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2008, 147, 85-95.
11. Schroeder, F.C., Taggi, A.E., Gronquist, M., Malik, R.U., Grant, J.B., Eisner, T., Meinwald, J. NMR spectroscopic screening of spider venom reveals sulfated nucleosides as major components for the brown recluse and related species. Proc. Natl. Acad. Sci. USA 2008, 105, 14283-14287.
12. Young, A.R., Pincus, S.J., Comparison of enzymatic activity from three species of necrotising arachnids in Australia: Loxosceles rufescens, Badumna insignis and Lampona cylindrata. Toxicon 2001, 39, 391-400.
13. Barbaro, K.C., Knysak, I., Martins, R., Hogan, C., Winkel, K. Enzymatic characterization, antigenic cross-reactivity and neutralization of dermonecrotic activity of five Loxosceles spider venoms of medical importance in the Americas. Toxicon 2005, 45, 489-499.
14. da Silveira, R.B., Chaim, O.M., Mangili, O.C., Gremski, W., Dietrich, C.P., Nader, H.B., Veiga, S.S. Hyaluronidases in Loxosceles intermedia (Brown spider) venom are endo-beta-N-acetyl-d-hexosaminidases hydrolases. Toxicon 2007, 49, 758-768.
15. Barbaro, K.C., Ferreira, M.L., Cardoso, D.F., Eickstedt, V.R., Mota, I. Identification and neutralization of biological activities in the venoms of Loxosceles spiders. Braz. J. Med. Biol. Res. 1996, 29, 1491-1497.
16. Cunha, R.B., Barbaro, K.C., Muramatsu, D., Portaro, F.C., Fontes, W., de Sousa, M.V. Purification and characterization of loxnecrogin, a dermonecrotic toxin from Loxosceles gaucho brown spider venom. J. Protein Chem. 2003, 22, 135-146.
17. Kalapothakis, E., Chatzaki, M., Goncalves-Dornelas, H., de Castro, C.S., Silvestre, F.G., Laborne, F.V., de Moura, J.F., Veiga, S.S., Chavez-Olortegui, C., Granier, C., Barbaro, K.C. The Loxtox protein family in Loxosceles intermedia (Mello-Leitao) venom. Toxicon 2007, 50, 938-946.
18. Feitosa, L., Gremski, W., Veiga, S.S., Elias, M.C., Graner, E., Mangili, O.C., Brentani, R.R. Detection and characterization of metalloproteinases with gelatinolytic, fibronectinolytic and fibrinogenolytic activities in brown spider (Loxosceles intermedia) venom. Toxicon 1998, 36, 1039-1051.
19. Veiga S.S., da Silveira R.B., Dreyfus J.L., Haoach J., Pereira, A.M., Mangili, O.C., Gremski, W. Identification of high molecular weight serine-proteases in Loxosceles intermedia (brown spider) venom. Toxicon 2000, 38, 825-839.
20. Veiga, S.S., Feitosa, L., dos Santos, V.L., de Souza, G.A., Ribeiro, A.S., Mangili, O.C., Porcionatto, M.A., Nader, H.B., Dietrich, C.P., Brentani, R.R., Gremski, W. Effect of brown spider venom on basement membrane structures. Histochem. J. 2000, 32, 397-408.
21. Veiga, S.S., Zanetti, V.C., Braz, A., Mangili, O.C., Gremski, W. Extracellular matrix molecules as targets for brown spider venom toxins. Braz. J. Med. Biol. Res. 2001, 34, 843-850.
22. Veiga, S.S., Zanetti, V.C., Franco, C.R., Trindade, E.S., Porcionatto, M.A., Mangili, O.C., Gremski, W., Dietrich, C.P., Nader H.B. In vivo and in vitro cytotoxicity of brown spider venom for blood vessel endothelial cells. Thromb. Res. 2001, 102, 229-237.
23. de Castro, C.S., Silvestre, F.G., Araujo, S.C.,de Gabriel M.Y., Mangili, O.C., Cruz, I., Chavez-Olortegui, C., Kalapothakis, E. Identification and molecular cloning of insecticidal toxins from the venom of the brown spider Loxosceles intermedia. Toxicon 2004, 44, 273-280.
24. dos Santos, L.D., Dias, N.B., Roberto, J., Pinto, A.S., Palma, M.S. Brown recluse spider venom: proteomic analysis and proposal of a putative mechanism of action. Protein Pept. Lett. 2009, 16, 933-943.
25. Machado, L.F., Laugesen, S., Botelho, E.D., Ricart, C.A., Fontes, W., Barbaro, K.C., Roepstorff, P., Sousa, M.V. Proteome analysis of brown spider venom: identification of loxnecrogin isoforms in Loxosceles gaucho venom. Proteomics 2005, 5, 2167-2176.
26. Corzo, G., Gilles, N., Satake, H., Villegas, E., Dai, L., Nakajima, T., Haupt, J. Distinct primary structures of the major peptide toxins from the venom of the spider Macrothele gigas that bind to sites 3 and 4 in the sodium channel. FEBS Lett. 2003, 547, 43-50.
27. Gremski, L.H., da Silveira, R.B., Chaim, O.M., Probst, C.M., Ferrer, V.P., Nowatzki, J., Weinschutz, H.C., Madeira, H.M., Gremski, W., Nader, H.B., Senff-Ribeiro, A., Veiga, S.S. A novel expression profile of the Loxosceles intermedia spider venomous gland revealed by transcriptome analysis. Mol. Biosyst. 2010, 6, 2403-2416.
28. Binford, G.J., Cordes, M.H., Wells, M.A. Sphingomyelinase D from venoms of Loxosceles spiders: evolutionary insights from cDNA sequences and gene structure. Toxicon 2005, 45, 547-560.
29. Trevisan-Silva, D., Gremski, L.H., Chaim, O.M., da Silveira, R.B., Meissner, G.O., Mangili, O.C., Barbaro, K.C., Gremski, W., Veiga, S.S., Senff-Ribeiro, A. Astacin like metalloproteases are a gene family of toxins present in the venom of different species of the brown spider (genus Loxosceles). Biochimie 2010, 92, 21-32.
30. Wood, D.L., Miljenovic, T., Cai, S., Raven, R.J., Kaas, Q., Escoubas, P., Herzig, V., Wilson, D., King, G.F., Arachno Server: A database of protein toxins from spiders. BMC Genomics 2009, 10, 375.
31. King, G.F., Gentz, M.C., Escoubas, P., Nicholson, G.M. A rational nomenclature for naming peptide toxins from spiders and other venomous animals. Toxicon 2008, 52, 264-276.
32. Kalapothakis, E., Araujo, S.C., de Castro, C.S., Mendes, T.M., Gomez, M.V., Mangili, O.C., Gubert, I.C., Chavez-Olortegui, C. Molecular cloning, expression and immunological properties of LiD1, a protein from the dermonecrotic family of Loxosceles intermedia spider venom. Toxicon 2002, 40, 1691-1699.
33. Tambourgi, D.V., Fernandes-Pedrosa, M.F., van den Berg, C.W., Goncalves-de-Andrade, R.M., Ferracini, M., Paixao-Cavalcante, D., Morgan, B.P., Rushmere, N.K. Molecular cloning, expression, function and immuno reactivities of members of a gene family of sphingomyelinases from Loxosceles venom glands. Mol. Immunol. 2004, 41, 831-840.
34. Appel, M.H., da Silveira, R.B., Chaim, O.M., Paludo, K.S., Silva, D.T., Chaves, D.M., da Silva, P.H., Mangili, O.C., Senff-Ribeiro, A., Gremski, W., Nader, H.B., Veiga, S.S. Identification, cloning and functional characterization of a novel dermonecrotic toxin (phospholipase D) from brown spider (Loxosceles intermedia) venom. Biochim. Biophys. Acta 2008, 1780, 167-178.
35. Chaim, O.M., Sade, Y.B., da Silveira, R.B., Toma, L., Kalapothakis, E., Chavez-Olortegui, C., Mangili, O.C., Gremski, W., von Dietrich, C.P., Nader, H.B., Veiga, S.S. Brown spider dermonecrotic toxin directly induces nephrotoxicity. Toxicol. Appl. Pharmacol. 2006, 211, 64-77.
36. da Silveira, R.B., Pigozzo, R.B., Chaim, O.M., Appel, M.H., Dreyfuss, J.L., Toma, L., Mangili, O.C., Gremski, W., Dietrich, C.P., Nader, H.B., Veiga, S.S. Molecular cloning and functional characterization of two isoforms of dermonecrotic toxin from Loxosceles intermedia (brown spider) venom gland. Biochimie 2006, 88, 1241-1253.
37. da Silveira, R.B., Pigozzo, R.B., Chaim, O.M., Appel, M.H., Silva, D.T., Dreyfuss, J.L., Toma, L., Dietrich, C.P., Nader, H.B., Veiga, S.S., Gremski, W. Two novel dermonecrotic toxins LiRecDT4 and LiRecDT5 from brown spider (Loxosceles intermedia) venom: From cloning to functional characterization. Biochimie 2007, 89, 289-300.
38. Ribeiro, R.O., Chaim, O.M., da Silveira, R.B., Gremski, L.H., Sade, Y.B., Paludo, K.S., Senff-Ribeiro, A., de Moura, J., Chavez-Olortegui, C., Gremski, W., Nader, H.B., Veiga, S.S. Biological and structural comparison of recombinant phospholipase D toxins from Loxosceles intermedia (brown spider) venom. Toxicon 2007, 50, 1162-1174.
39. Ramos-Cerrillo, B., Olvera, A., Odell, G.V., Zamudio, F., Paniagua-Solis, J., Alagon, A., Stock, R.P. Genetic and enzymatic characterization of sphingomyelinase D isoforms from the North American fiddle back spiders Loxosceles boneti and Loxosceles reclusa. Toxicon 2004, 44, 507-514.
40. Murakami, M.T., Fernandes-Pedrosa, M.F., de Andrade, S.A., Gabdoulkhakov, A., Betzel, C., Tambourgi, D.V., Arni, R.K. Structural insights into the catalytic mechanism of sphingomyelinases D and evolutionary relationship to glycerophosphodiester phosphodiesterases. Biochem. Biophys. Res. Commun. 2006, 342, 323-329.
41. Lee, S., Lynch, K.R. Brown recluse spider (Loxosceles reclusa) venom phospholipase D (PLD) generates lysophosphatidic acid (LPA). Biochem. J. 2005, 391, 317-323.
42. Chaim, O.M., da Silveira, R.B., Trevisan-Silva, D., Ferrer, V.P., Sade, Y.B., Bóia-Ferreira, M., Gremski, L.H., Gremski, W., Senff-Ribeiro, A., Takahashi, H.K., Toledo, M.S., Nader, H.B., Veiga, S.S. Phospholipase-D activity and inflammatory response induced by brown spider dermonecrotic toxin: Endothelial cell membrane phospholipids as targets for toxicity. BBA Mol. Cell Biol. Lipids 2010, 1811, 84-96.
43. Fernandes Pedrosa, M.F., Junqueira de Azevedo I. de, L., Goncalves-de-Andrade, R.M., van den Berg, C.W., Ramos, C.R., Ho, P.L., Tambourgi, D.V. Molecular cloning and expression of a functional dermonecrotic and haemolytic factor from Loxosceles laeta venom. Biochem. Biophys. Res. Commun. 2002, 298, 638-645.
44. Tambourgi, D.V., Magnoli, F.C., Von Eickstedt, V.R., Benedetti, Z.C., Petricevich, V.L., da Silva, W.D. Incorporation of a. 35-kilodalton purified protein from Loxosceles intermedia spider venom transforms human erythrocytes into activators of autologous complement alternative pathway. J. Immunol. 1995, 155, 4459-4466.
45. Chaves-Moreira, D., Chaim, O.M., Sade, Y.B., Paludo, K.S., Gremski, L.H., Donatti, L., de Moura, J., Mangili, O.C., Gremski, W., da Silveira, R.B., Senff-Ribeiro, A., Veiga, S.S. Identification of a direct hemolytic effect dependent on the catalytic activity induced by phospholipase-D (dermonecrotic toxin) from brown spider venom. J. Cell. Biochem. 2009, 107, 655-666.
46. Kusma, J., Chaim, O.M., Wille, A.C., Ferrer, V.P., Sade, Y.B., Donatti, L., Gremski, W., Mangili, O.C., Veiga, S.S. Nephrotoxicity caused by brown spider venom phospholipase-D (dermonecrotic toxin) depends on catalytic activity. Biochimie 2008, 90, 1722-1736.
47. Barbaro, K.C., Sousa, M.V., Morhy, L., Eickstedt, V.R., Mota, I. Compared chemical properties of dermonecrotic and lethal toxins from spiders of the genus Loxosceles (Araneae). J. Protein Chem. 1996, 15, 337-343.
48. van Meeteren, L.A., Frederiks, F., Giepmans, B.N., Pedrosa, M.F., Billington, S.J., Jost, B.H., Tambourgi, D.V., Moolenaar, W.H. Spider and bacterial sphingomyelinases D target cellular lysophosphatidic acid receptors by hydrolyzing lysophosphatidylcholine. J. Biol. Chem. 2004, 279, 10833-10836.
49. Dragulev, B., Bao, Y., Ramos-Cerrillo, B., Vazquez, H., Olvera, A., Stock, R., Algaron, A., Fox, J.W. Upregulation of IL-6, IL-8, CXCL1, and CXCL2 dominates gene expression in human fibroblast cells exposed to Loxosceles reclusa sphingomyelinase D: Insights into spider venom dermonecrosis. J. Invest. Dermatol. 2007, 127, 1264-1266.
50. Barrett, S.M., Romine-Jenkins, M., Blick, K.E. Passive hemagglutination inhibition test for diagnosis of brown recluse spider bite envenomation. Clin. Chem. 1993, 39, 2104-2107.
51. Fernandes-Pedrosa, F., Junqueira-de-Azevedo, L., Goncalves-de-Andrade, R.M., Kobashi, L.S., Almeida, D.D., Ho, P.L., Tambourgi, D.V. Transcriptome analysis of Loxosceles laeta (Araneae, Sicariidae) spider venomous gland using expressed sequence tags. BMC Genomics 2008, 9, 279.
52. da Silveira, R.B., Wille, A.C., Chaim, O.M., Appel, M.H., Silva, D.T., Franco, C.R., Toma, L., Mangili, O.C., Gremski, W., Dietrich, C.P., Nader, H.B., Veiga, S.S. Identification, cloning, expression and functional characterization of an astacin-like metalloprotease toxin from Loxosceles intermedia (brown spider) venom. Biochem. J. 2007, 406, 355-363.
53. da Silveira, R.B., dos Santos Filho, J.F., Mangili, O.C., Veiga, S.S., Gremski, W., Nader, H.B., von Dietrich, C.P. Identification of proteases in the extract of venom glands from brown spiders. Toxicon 2002, 40, 815-822.
54. Stocker, W., Grams, F., Baumann, U., Reinemer, P., Gomis-Ruth, F.X., McKay, D.B., Bode, W. The metzincins--topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases. Protein Sci. 1995, 4, 823-840.
55. Wright, R.P., Elgert, K.D., Campbell, B.J., Barrett, J.T. Hyaluronidase and esterase activities of the venom of the poisonous brown recluse spider. Arch. Biochem. Biophys. 1973, 159, 415-426.
56. Bommer, U.A., Thiele, B.J. The translationally controlled tumour protein (TCTP). Int. J. Biochem. Cell Biol. 2004, 36, 379-385.
57. Marsh, N., Williams, V. Practical applications of snake venom toxins in haemostasis. Toxicon 2005, 45, 1171-1181.
58. Koh, D.C., Armugam, A., Jeyaseelan, K. Snake venom components and their applications in biomedicine. Cell Mol. Life Sci. 2006, 63, 3030-3041.
59. Bailey, P., Wilce, J. Venom as a source of useful biologically active molecules. Emerg. Med. (Fremantle) 2001, 13, 28-36.
60. Schmidtko, A., Lotsch, J., Freynhagen, R., Geisslinger, G. Ziconotide for treatment of severe chronic pain. Lancet 2010, 375, 1569-1577.
61. Ramu, Y., Xu, Y., Lu, Z. Engineered specific and high-affinity inhibitor for a subtype of inward-rectifier K+ channels. Proc. Natl. Acad. Sci. USA 2008, 105, 10774-10778.
62. Gedulin, B.R., Smith, P., Prickett, K.S., Tryon, M., Barnhill, S., Reynolds, J., Nielsen, L.L., Parkes, D.G., Young, A.A. Dose response for glycaemic and metabolic changes. 28 days after single injection of long-acting release exenatide in diabetic fatty Zucker rats. Diabetologia 2005, 48, 1380-1385.
63. Heine, R.J., Van Gaal, L.F., Johns, D., Mihm, M.J., Widel, M.H., Brodows, R.G. Exenatide versus insulin glargine in patients with sub optimally controlled type. 2 diabetes: A randomized trial. Ann. Intern. Med. 2005, 143, 559-569.
64. Chuang, R.S., Jaffe, H., Cribbs, L., Perez-Reyes, E., Swartz, K.J. Inhibition of T type voltage-gated calcium channels by a new scorpion toxin. Nat. Neurosci. 1998, 1, 668-674.
65. Bagdany, M., Batista, C.V., Valdez-Cruz, N.A., Somodi, S., Rodriguez de la Vega R.C., Licea, A.F., Varga, Z., Gaspar, R., Possani, L.D., Panyi, G. Anuroctoxin, a new scorpion toxin of the alpha-KTx. 6 subfamily, is highly selective for Kv1.3 over IKCa1 ion channels of human T lymphocytes. Mol. Pharmacol. 2005, 67, 1034-1044.
66. Gurevitz, M., Karbat, I., Cohen, L., Ilan, N., Kahn, R., Turkov, M., Stankiewicz, M., Stuhmer, W., Dong, K., Gordon, D. The insecticidal potential of scorpion beta-toxins. Toxicon 2007, 49, 473-489.
67. Diochot, S., Lazdunski, M. Sea anemone toxins affecting potassium channels. Prog. Mol. Subcell. Biol. 2009, 46, 99-122.
68. Mirshafiey, A. Venom therapy in multiple sclerosis. Neuropharmacology 2007, 53, 353-361.
69. Norton, R.S., Pennington, M.W., Wulff, H. Potassium channel blockade by the sea anemone toxin ShK for the treatment of multiple sclerosis and other autoimmune diseases. Curr. Med. Chem. 2004, 11, 3041-3052.
70. Fletcher, J.I., Smith, R., O'Donoghue, S.I., Nilges, M., Connor, M., Howden, M.E., Christie, M.J., King, G.F. The structure of a novel insecticidal neurotoxin, omega-atracotoxin-HV1, from the venom of an Australian funnel web spider. Nat. Struct. Biol. 1997, 4, 559-566.
71. Villanova, F.E., Andrade, E., Leal, E., Andrade, P.M., Borra, R.C., Troncone, L.R., Magalhaes, L., Leite, K.R., Paranhos, M., Claro, J., Srougi, M. Erection induced by Tx2-6 toxin of Phoneutria nigriventer spider: expression profile of genes in the nitric oxide pathway of penile tissue of mice. Toxicon 2009, 54, 793-801.
72. Andrade, E., Villanova, F., Borra, P., Leite, K., Troncone, L., Cortez, I., Messina, L., Paranhos, M., Claro, J., Srougi, M. Penile erection induced in vivo by a purified toxin from the Brazilian spider Phoneutria nigriventer. BJU Int. 2008, 102, 835-837.
73. Haeberli, S., Kuhn-Nentwig, L., Schaller, J., Nentwig, W. Characterization of antibacterial activity of peptides isolated from the venom of the spider Cupiennius salei (Araneae: Ctenidae). Toxicon 2000, 38, 373-380.
74. Senff-Ribeiro, A., Henrique da Silva, P., Chaim, O.M., Gremski, L.H., Paludo, K.S., Bertoni da Silveira, R., Gremski, W., Mangili, O.C., Veiga, S.S. Biotechnological applications of brown spider (Loxosceles genus) venom toxins. Biotechnol. Adv. 2008, 26, 210-218.
75. Veiga, S.S. Federal University of Paraná, Paraná, Brazil, Personal communication, 2011.
76. Binford, G.J., Wells, M.A. The phylogenetic distribution of sphingomyelinase D activity in venoms of Haplogyne spiders. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 2003, 135, 25-33.
77. Tambourgi, D.V., Goncalves-de-Andrade, R.M., van den Berg, C.W. Loxoscelism: From basic research to the proposal of new therapies. Toxicon 2010, 56, 1113-1119.
78. Barbaro, K.C., Eickstedt, V.R., Mota, I. Antigenic cross reactivity of venoms from medically important Loxosceles (Araneae) species in Brazil. Toxicon 1994, 32, 113-120.
79. Mota, I., Barbaro, K.C. Biological and biochemical properties of venoms from medically important Loxosceles (Araneae) species in Brazil. Toxin Rev. 1995, 14, 401-421.
80. Luciano, M.N., da Silva, P.H., Chaim, O.M., dos Santos, V.L., Franco, C.R., Soares, M.F., Zanata, S.M., Mangili, O.C., Gremski, W., Veiga, S.S. Experimental evidence for a direct cytotoxicity of Loxosceles intermedia (brown spider) venom in renal tissue. J. Histochem. Cytochem. 2004, 52, 455-467.
81. Paixao-Cavalcante, D., van den Berg, C.W., Freitas Fernandes Pedrosa M., Goncalves de Andrade, R.M., Tambourgi, D.V. Role of matrix metalloproteinases in HaCaT keratinocytes apoptosis induced by loxosceles venom sphingomyelinase D. J. Invest. Dermatol. 2006, 126, 61-68.
82. McGlasson, D.L., Green, J.A., Stoecker, W.V., Babcock, J.L., Calcara, D.A. Duration of Loxosceles reclusa venom detection by ELISA from swabs. Clin. Lab. Sci. 2009, 22, 216-222.
83. Vetter, R.S. Arachnids misidentified as brown recluse spiders by medical personnel and other authorities in North America. Toxicon 2009, 54, 545-547.
84. Reitz, M. Diagnosis of brown recluse spider bites is overused. Am. Fam. Physician 2007, 76, 943-944.
85. Pauli, I., Minozzo, J.C., da Silva, P.H., Chaim, O.M., Veiga, S.S. Analysis of therapeutic benefits of antivenin at different time intervals after experimental envenomation in rabbits by venom of the Brown spider (Loxosceles intermedia). Toxicon 2009, 53, 660-671.
86. Pauli, I., Puka, J., Gubert, I.C., Minozzo, J.C. The efficacy of antivenom in loxoscelism treatment. Toxicon 2006, 48, 123-137.
87. Dias-Lopes, C., Guimaraes, G., Felicori, L., Fernandes, P., Emery, L., Kalapothakis, E., Nguyen, C., Molina, F., Granier, C., Chavez-Olortegui, C. A protective immune response against lethal, dermonecrotic and hemorrhagic effects of Loxosceles intermedia venom elicited by a. 27-residue peptide. Toxicon 2010, 55, 481-487.
88. Felicori, L., Fernandes, P.B., Giusta, M.S., Duarte, C.G., Kalapothakis, E., Nguyen, C., Molina, F., Granier, C., Chavez-Olortegui, C. An in. vivo protective response against toxic effects of the dermonecrotic protein from Loxosceles intermedia spider venom elicited by synthetic epitopes. Vaccine 2009, 27, 4201-4208.
89. Gomez, H.F., Krywko, D.M., Stoecker, W.V. A new essay for the detection of Loxosceles species (brown recluse) spider venom. Ann. Emerg. Med. 2002, 39, 469-474.
90. Krywko, D.M., Gomez, H.F. Detection of Loxosceles species venom in dermal lesions: A comparison of 4 venom recovery methods. Ann. Emerg. Med. 2002, 39, 475-480.
91. McDermott, M., Wakelam, M.J., Morris, A.J. Phospholipase D. Biochem. Cell. Biol. 2004, 82, 225-253.
92. Gomez-Cambronero, J. New concepts in phospholipase D signaling in inflammation and cancer. Sci. World J. 2010, 10, 1356-1369.
93. Roth, M.G. Molecular mechanisms of PLD function in membrane traffic. Traffic 2008, 9, 1233-1239.
94. Huwiler, A., Kolter, T., Pfeilschifter, J., Sandhoff, K. Physiology and pathophysiology of sphingolipid metabolism and signaling. Biochim. Biophys. Acta 2000, 1485, 63-99.
95. Mitsutake, S., Igarashi, Y. Transbi layer movement of ceramide in the plasma membrane of live cells. Biochem. Biophys. Res. Commun. 2007, 359, 622-627.
96. Rodrigues, R.S., Izidoro, L.F., de Oliveira, R.J., Jr., Sampaio, S.V., Soares, A.M., Rodrigues, V.M. Snake venom phospholipases A2: A new class of antitumor agents. Protein Pept. Lett. 2009, 16, 894-898.
97. Su, W., Chen, Q., Frohman, M.A. Targeting phospholipase D with small molecule inhibitors as a potential therapeutic approach for cancer metastasis. Future Oncol. 2009, 5, 1477-1486.
98. Majd, S., Yusko, E.C., MacBriar, A.D., Yang, J., Mayer, M. Gramicidin pores report the activity of membrane-active enzymes. J. Am. Chem. Soc. 2009, 131, 16119-16126.
99. Ramu, Y., Xu, Y., Lu, Z. Enzymatic activation of voltage-gated potassium channels. Nature 2006, 442, 696-699.
100. Menzel E.J., Farr C. Hyaluronidase and its substrate hyaluronan: Biochemistry, biological activities and therapeutic uses. Cancer Lett. 1998, 131, 3-11.
101. Cramer, J.A., Bailey, L.C., Bailey, C.A., Miller, R.T. Kinetic and mechanistic studies with bovine testicular hyaluronidase. Biochim. Biophys. Acta 1994, 1200, 315-321.
102. Girish K.S., Kemparaju K. The magic glue hyaluronan and its eraser hyaluronidase: A biological overview. Life Sci. 2007, 80, 1921-1943.
103. Kemparaju, K., Girish, K.S. Snake venom hyaluronidase: a therapeutic target. Cell Biochem. Funct. 2006, 24, 7-12.
104. Magalhaes, M.R., da Silva, N.J., Jr., Ulhoa, C.J. A hyaluronidase from Potamotrygon motoro (freshwater stingrays) venom: Isolation and characterization. Toxicon 2008, 51, 1060-1067.
105. Girish, K.S., Kemparaju, K. A low molecular weight isoform of hyaluronidase: purification from Indian cobra (Naja naja) venom and partial characterization. Biochemistry (Mosc) 2005, 70, 708-712.
106. Markovic-Housley, Z., Miglierini, G., Soldatova, L., Rizkallah, P.J., Muller, U., Schirmer, T. Crystal structure of hyaluronidase, a major allergen of bee venom. Structure 2000, 8, 1025-1035.
107. Skov, L.K., Seppala, U., Coen, J.J., Crickmore, N., King, T.P., Monsalve, R., Kastrup, J.S., Spangfort, M.D., Gajhede, M. Structure of recombinant Ves v. 2 at 2.0 Angstrom resolution: structural analysis of an allergenic hyaluronidase from wasp venom. Acta Crystallogr. D Biol. Crystallogr. 2006, 62, 595-604.
108. Tan N.H., Ponnudurai G. Comparative study of the enzymatic, hemorrhagic, procoagulant and anticoagulant activities of some animal venoms. Comp. Biochem. Physiol. C 1992, 103, 299-302.
109. Kaiser E. Trypsin and hyaluronidase inhibitor of human serum, the inhibition of the proteolytic and hyaluronic acid cleavage enzymes of snake and spider venoms by human serum. Biochem. J. 1953, 324, 344-350.
110. Nagaraju, S., Devaraja, S., Kemparaju, K. Purification and properties of hyaluronidase from Hippasa partita (funnel web spider) venom gland extract. Toxicon 2007, 50, 383-393.
111. Rash, L.D., Hodgson, W.C. Pharmacology and biochemistry of spider venoms. Toxicon 2002, 40, 225-254.
112. Kuhn-Nentwig, L., Schaller, J., Nentwig, W. Biochemistry, toxicology and ecology of the venom of the spider Cupiennius salei (Ctenidae). Toxicon 2004, 43, 543-553.
113. Nagaraju, S., Mahadeswaraswamy, Y.H., Girish, K.S., Kemparaju, K. Venom from spiders of the genus Hippasa: Biochemical and pharmacological studies. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2006, 144, 1-9.
114. Rocha-e-Silva, T.A.A., Sutti, R., Hyslop, S. Milking and partial characterization of venom from the Brazilian spider Vitalius dubius (Theraphosidae). Toxicon 2009, 53, 153-161.
115. Zobel-Thropp, P.A., Bodner, M.R., Binford, G.J. Comparative analyses of venoms from American and African Sicarius spiders that differ in sphingomyelinase D activity. Toxicon 2010, 55, 1274-1282.
116. Goolsby, T.V., Lombardo, F.A. Extra vasation of Chemotherapeutic Agents: Prevention and Treatment. Semin. Oncol. 2006, 33, 139-143.
117. Dunn, A.L., Heavner, J.E., Racz, G., Day, M. Hyaluronidase: A review of approved formulations, indications and off-label use in chronic pain management. Expert Opin. Biol. Ther. 2010, 10, 127-131.
118. Muchmore, D.B., Vaughn, D.E. Review of the mechanism of action and clinical efficacy of recombinant human hyaluronidase coadministration with current prandial insulin formulations. J. Diabetes Sci. Technol. 2010, 4, 419-428.
119. Etesse, B., Beaudroit, L., Deleuze, M., Nouvellon, E., Ripart, J. Hyaluronidase: Here we go again. Ann. Fr. Anesth. Reanim. 2009, 28, 658-665.
120. Misbah, S., Sturzenegger, M.H., Borte, M., Shapiro, R.S., Wasserman, R.L., Berger, M., Ochs, H.D. Subcutaneous immunoglobulin: opportunities and outlook. Clin. Exp. Immunol. 2009, 158, 51-59.
121. Lokeshwar, V.B., Selzer, M.G. Hyalurondiase: Both a tumor promoter and suppressor. Semin. Cancer Biol. 2008, 18, 281-287.
122. Barla, F., Higashijima, H., Funai, S., Sugimoto, K., Harada, N., Yamaji, R., Fujita, T., Nakano, Y., Inui, H., Inhibitive effects of alkyl gallates on hyaluronidase and collagenase. Biosci. Biotechnol. Biochem. 2009, 73, 2335-2337.
123. Shuster, S., Frost, G.I., Csoka, A.B., Formby, B., Stern, R. Hyaluronidase reduces human breast cancer xenografts in SCID mice. Int. J. Cancer 2002, 102, 192-197.
124. Botzki, A., Rigden, D.J., Braun, S., Nukui, M., Salmen, S., Hoechstetter, J., Bernhardt, G., Dove, S., Jedrzejas, M.J., Buschauer, A. L-Ascorbic acid. 6-hexadecanoate, a potent hyaluronidase inhibitor. X-ray structure and molecular modeling of enzyme-inhibitor complexes. J. Biol. Chem. 2004, 279, 45990-45997.
125. Calvete, J.J. Venomics: Digging into the evolution of venomous systems and learning to twist nature to fight pathology. J. Proteomics 2009, 72, 121-126.
126. Escoubas, P., King, G.F. Venomics as a drug discovery platform. Expert Rev. Proteomics 2009, 6, 221-224.
127. Gross, B., Gaestel, M., Bohm, H., Bielka, H. cDNA sequence coding for a translationally controlled human tumor. Protein Nucleic Acids Res. 1989, 17, 8367.
128. MacDonald, S.M., Rafnar, T., Langdon, J., Lichtenstein, L.M. Molecular identification of an IgE dependent histamine-releasing factor. Science 1995, 269, 688-690.
129. Choi, K.W., Hsu, Y.C. To cease or to proliferate: New insights into TCTP function from a Drosophila study. Cell Adh. Migr. 2007, 1, 129-130.
130. Sun, J., Wu, Y., Wang, J., Ma, F., Liu, X., Li, Q. Novel translationally controlled tumor protein homologue in the buccal gland secretion of Lampetra japonica. Biochimie 2008, 90, 1760-1768.
131. Gachet, Y., Tournier, S., Lee, M., Lazaris-Karatzas, A., Poulton, T., Bommer, U.A. The growth-related, translationally controlled protein P23 has properties of a tubulin binding protein and associates transiently with microtubules during the cell cycle. J. Cell. Sci. 1999, 112, 1257-1271.
132. Bazile, F., Pascal, A., Arnal, I., Le Clainche, C., Chesnel, F., Kubiak, J.Z. Complex relationship between TCTP, microtubules and actin microfilaments regulates cell shape in normal and cancer cells. Carcinogenesis 2009, 30, 555-565.
133. Yarm, F.R. Plk phosphorylation regulates the microtubule-stabilizing protein TCTP. Mol. Cell. Biol. 2002, 22, 6209-6221.
134. Cans, C., Passer, B.J., Shalak, V., Nancy-Portebois, V., Crible, V., Amzallag, N., Allanic, D., Tufino, R., Argentini, M., Moras, D., Fiucci, G., Goud, B., Mirande, M., Amson, R., Telerman, A. Translationally controlled tumor protein acts as a guanine nucleotide dissociation inhibitor on the translation elongation factor eEF1A. Pro. Natl. Acad. Sci. USA 2003, 100, 13892-13897.
135. Liu, H., Peng, H.W., Cheng, Y.S., Yuan, H.S., Yang-Yen, H.F. Stabilization and enhancement of the antiapoptotic activity of mcl-1 by TCTP. Mol. Cell. Biol. 2005, 25, 3117-3126.
136. Li, F., Zhang, D., Fujise, K. Characterization of fortilin, a novel antiapoptotic. Protein J. Biol. Chem. 2001, 276, 47542-47549.
137. Amzallag, N., Passer, B.J., Allanic, D., Segura, E., Thery, C., Goud, B., Amson, R., Telerman, A. TSAP6 facilitates the secretion of translationally controlled tumor protein-histamine-releasing factor via a non classical pathway. J. Biol. Chem. 2004, 279, 46104-46112.
138. Jung, J., Kim, M., Kim, M.J., Kim, J., Moon, J., Lim, J.S., Kim, M., Lee, K. Translationally controlled tumor protein interacts with the third cytoplasmic domain of Na,K-ATPase alpha subunit and inhibits the pump activity in HeLa cells. J. Biol. Chem. 2004, 279, 49868-49875.
139. Yang, Y., Yang, F., Xiong, Z., Yan, Y., Wang, X., Nishino, M., Mirkovic, D., Nguyen, J., Wang, H., Yang, X.F. An N-terminal region of translationally controlled tumor protein is required for its antiapoptotic activity. Oncogene 2005, 24, 4778-4788.
140. Burgess, A., Labbe, J.C., Vigneron, S., Bonneaud, N., Strub, J.M., Van Dorsselaer, A., Lorca, T., Castro, A. Chfr interacts and colocalizes with TCTP to the mitotic spindle. Oncogene 2008, 27, 5554-5566.
141. Chen, S.H., Wu, P.S., Chou, C.H., Yan, Y.T., Liu, H., Weng, S.Y., Yang-Yen, H.F. A knockout mouse approach reveals that TCTP functions as an essential factor for cell proliferation and survival in a tissue- or cell type-specific manner. Mol. Biol. Cell 2007, 18, 2525-2532.
142. Hsu, Y., Chern, J.J., Cai, Y., Liu, M., Choi, K.W. Drosophila TCTP is essential for growth and proliferation through regulation of dRheb GTPase. Nature 2007, 445, 785-788.
143. Bheekha-Escura, R., MacGlashan Jr, D.W., Langdon, J.M., MacDonald, S.M. Human recombinant histamine-releasing factor activates human eosinophils and the eosinophilic cell line, AML14-3D10. Blood 2000, 96, 2191.
144. Kang, H.S., Lee, M.J., Song, H., Han, S.H., Kim, Y. M., Im, J.Y., Choi, I. Molecular Identification of IgE-Dependent Histamine-Releasing Factor as a B Cell Growth Factor. 1. J. Immunol. 2001, 166, 6545-6554.
145. Hinojosa-Moya, J., Xoconostle-Cazares, B., Piedra-Ibarra, E., Mendez-Tenorio, A., Lucas, W.J., Ruiz-Medrano, R. Phylogenetic and structural analysis of translationally controlled tumor proteins. J. Mol. Evol. 2008, 66, 472-483.
146. Mulenga, A., Azad, A.F. The molecular and biological analysis of ixodid ticks histamine release factors. Exp. Appl. Acarology 2005, 37, 215-229.
147. Rattmann, Y.D., Pereira, C.R., Cury, Y., Gremski, W., Marques, M.C.A., da Silva-Santos, J.E. Vascular permeability and vasodilation induced by the Loxosceles intermedia venom in rats: Involvement of mast cell degranulation, histamine and. 5-HT receptors. Toxicon 2008, 51, 363-372.
148. Rash, L.D., King, R.G., Hodgson, W.C. Evidence that histamine is the principal pharmacological component of venom from an Australian wolf spider (Lycosa godeffroyi). Toxicon 1998, 36, 367-375.
149. Paludo, K.S., Biscaia, S.M., Chaim, O.M., Otuki, M.F., Naliwaiko, K., Dombrowski, P.A., Franco, C.R., Veiga, S.S. Inflammatory events induced by brown spider venom and its recombinant dermonecrotic toxin: A pharmacological investigation. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2009, 149, 323-333.
150. Weisel-Eichler, A., Libersat, F. Venom effects on monoaminergic systems. J. Comp. Physiol. A Neuroethology Sens. Neural Behav. Physiol. 2004, 190, 683-690.
151. Rattmann, Y.D., Pereira, C.R., Cury, Y., Gremski, W., Marques, M.C., da Silva-Santos, J.E. Vascular permeability and vasodilation induced by the Loxosceles intermedia venom in rats: involvement of mast cell degranulation, histamine and. 5-HT receptors. Toxicon 2008, 51, 363-372.
152. Gnanasekar, M., Rao, K.V., Chen, L., Narayanan, R.B., Geetha, M., Scott, A.L., Ramaswamy, K., Kaliraj, P. Molecular characterization of a calcium binding translationally controlled tumor protein homologue from the filarial parasites Brugia malayi and Wuchereria bancrofti. Mol. Biochem. Parasitol. 2002, 121, 107-118.
153. MacDonald, S.M., Bhisutthibhan, J., Shapiro, T.A., Rogerson, S.J., Taylor, T.E., Tembo, M., Langdon, J.M., Meshnick, S.R. Immune mimicry in malaria: Plasmodium falciparum secretes a functional histamine-releasing factor homolog in vitro and in vivo. Proc. Natl. Acad. Sci. USA 2001, 98, 10829-10832.
154. Rao, K.V., Chen, L., Gnanasekar, M., Ramaswamy, K. Cloning and characterization of a calcium-binding, histamine-releasing protein from Schistosoma mansoni. J. Biol. Chem. 2002, 277, 31207-31213.
155. Efferth, T. Antiplasmodial and antitumor activity of artemisinin from bench to bedside. Planta Med. 2007, 73, 299.
156. Susini, L., Besse, S., Duflaut, D., Lespagnol, A., Beekman, C., Fiucci, G., Atkinson, A.R., Busso, D., Poussin, P., Marine, J.C., Martinou, J.C., Cavarelli, J., Moras, D., Amson, R., Telerman, A. TCTP protects from apoptotic cell death by antagonizing bax function. Cell Death Differ. 2008, 15, 1211-1220.
157. Gnanasekar, M., Thirugnanam, S., Zheng, G., Chen, A., Ramaswamy, K. Gene silencing of translationally controlled tumor protein (TCTP) by siRNA inhibits cell growth and induces apoptosis of human prostate cancer cells. Int. J. Oncol. 2009, 34, 1241-1246.
158. Telerman, A., Amson, R. The molecular programme of tumor reversion: the steps beyond malignant transformation. Nat. Rev. Cancer 2009, 9, 206-216.
159. Tuynder, M., Fiucci, G., Prieur, S., Lespagnol, A., Geant, A., Beaucourt, S., Duflaut, D., Besse, S., Susini, L., Cavarelli, J., Moras, D., Amson, R., Telerman, A. Translationally controlled tumor protein is a target of tumor reversion. Proc. Natl. Acad. Sci. USA 2004, 101, 15364-15369.
160. Slaby, O., Sobkova, K., Svoboda, M., Garajova, I., Fabian, P., Hrstka, R., Nenutil, R., Sachlova, M., Kocakova, I., Michalek, J., Smerdova, T., Knoflickova, D., Vyzula, R. Significant over expression of Hsp110 gene during colorectal cancer progression. Oncol. Rep. 2009, 21, 1235-1241.
161. Ma, Q., Geng, Y., Xu, W., Wu, Y., He, F., Shu, W., Huang, M., Du, H., Li, M. The Role of Translationally Controlled Tumor Protein in Tumor Growth and Metastasis of Colon Adenocarcinoma Cells. J. Proteome. Res. 2009, 9, 40-49.
162. Tuynder, M., Susini, L., Prieur, S., Besse, S., Fiucci, G., Amson, R., Telerman, A. Biological models and genes of tumor reversion: Cellular reprogramming through tpt1/TCTP and SIAH-1. Proc. Natl. Acad. Sci. USA 2002, 99, 14976-14981.
163. Efferth, T. Mechanistic perspectives for. 1,2,4-trioxanes in anti-cancer therapy. Drug Resist. Updat. 2005, 8, 85-97.
164. Kim, J.E., Koo, K.H., Kim, Y.H., Sohn, J., Park, Y.G. Identification of potential lung cancer biomarkers using an in vitro carcinogenesis model. Exp. Mol. Med. 2008, 40, 709-720.
165. van de Sande, W.W., Janse, D.J., Hira, V., Goedhart, H., van der Zee, R., Ahmed, A.O., Ott, A., Verbrugh, H., van Belkum, A. Translationally controlled tumor protein from Madurella mycetomatis, a marker for tumorous mycetoma progression. J. Immunol. 2006, 177, 1997-2005.
166. Zhu, W.L., Cheng, H.X., Han, N., Liu, D.L., Zhu, W.X., Fan, B.L., Duan, F.L. Messenger RNA expression of translationally controlled tumor protein (TCTP) in liver regeneration and cancer. Anticancer Res. 2008, 28, 1575-1580.
167. Rinnerthaler, M., Jarolim, S., Heeren, G., Palle, E., Perju, S., Klinger, H., Bogengruber, E., Madeo, F., Braun, R.J., Breitenbach-Koller, L., Breitenbach, M., Laun, P. MMI1 (YKL056c, TMA19), the yeast orthologue of the translationally controlled tumor protein (TCTP) has apoptotic functions and interacts with both microtubules and mitochondria. Biochim. Biophys. Acta 2006, 1757, 631-638.
168. Zanetti, V.C., da Silveira, R.B., Dreyfuss, J.L., Haoach, J., Mangili, O.C., Veiga, S.S., Gremski, W. Morphological and biochemical evidence of blood vessel damage and fibrinogenolysis triggered by brown spider venom. Blood Coagul. Fibrinolysis 2002, 13, 135-148.
169. Gomis-Rüth, F. Structural aspects of the metzincin clan of metalloendopeptidases. Mol. Biotechnol. 2003, 24, 157-202.
170. Sterchi, E.E. Special issue: Metzincin metalloproteinases. Mol. Aspects Med. 2008, 29, 255-257.
171. Becker-Pauly, C., Bruns, B.C., Damm, O., Schutte, A., Hammouti, K., Burmester, T., Stocker, W. News from an ancient world: two novel astacin metalloproteases from the horseshoe crab. J. Mol. Biol. 2009, 385, 236-248.
172. Sarras, M.P., Jr., BMP-1 and the astacin family of metalloproteinases: A potential link between the extracellular matrix, growth factors and pattern formation. Bioessays 1996, 18, 439-442.
173. Mohrlen, F., Hutter, H., Zwilling, R. The astacin protein family in Caenorhabditis elegans. Eur. J. Biochem. 2003, 270, 4909-4920.
174. Bode, W., Gomis-Ruth, F.X., Stockler, W. Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the 'metzincins'. FEBS Lett. 1993, 331, 134-140.
175. Bond, J.S., Beynon, R.J. The astacin family of metalloendopeptidases. Protein Sci. 1995, 4, 1247-1261.
176. Stocker, W., Zwilling, R. Astacin. Methods Enzymol. 1995, 248, 305-325.
177. Stocker, W., Bode, W. Structural features of a superfamily of zinc endopeptidases: The metzincins. Curr. Opin. Struct. Biol. 1995, 5, 383-390.
178. Dumermuth, E., Sterchi, E.E., Jiang, W.P., Wolz, R.L., Bond, J.S., Flannery, A.V., Beynon, R.J. The astacin family of metalloendopeptidases. J. Biol. Chem. 1991, 266, 21381-21385.
179. Sharma, V.K., Teoh, H.L., Wong, L.Y., Su, J., Ong, B.K., Chan, B.P. Recanalization therapies in acute ischemic stroke: pharmacological agents, devices, and combinations. Stroke Res. Treat. 2010, in press.
180. Gao, F., Kiesewetter, D., Chang, L., Ma, K., Rapoport, S.I., Igarashi, M. Whole body synthesis secretion of docosahexaenoic acid from circulating eicosapentaenoic acid in un anesthetized rats. J. Lipid Res. 2009, 50, 2463-2470.
181. Rash, L.D., Hodgson, W.C. Pharmacology and biochemistry of spider venoms. Toxicon 2002, 40, 225-254.
182. Nicholson, G.M. Insect selective spider toxins targeting voltage-gated sodium channels. Toxicon 2007, 49, 490-512.
183. De Lima, M.E., Figueiredo, S.G., Pimenta, A.M., Santos, D.M., Borges, M.H., Cordeiro, M.N., Richardson, M., Oliveira, L.C., Stankiewicz, M., Pelhate, M. Peptides of arachnid venoms with insecticidal activity targeting sodium channels. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2007, 146, 264-279.
184. Sollod, B.L., Wilson, D., Zhaxybayeva, O., Gogarten, J.P., Drinkwater, R., King, G.F. Were arachnids the first to use combinatorial peptide libraries? Peptides 2005, 26, 131-139.
185. Grishin, E. Polypeptide neurotoxins from spider venoms. Eur. J. Biochem. 1999, 264, 276-280.
186. Escoubas, P., Diochot, S., Corzo, G. Structure and pharmacology of spider venom neurotoxins. Biochimie 2000, 82, 893-907.
187. Dutra, A.A., Sousa, L.O., Resende, R.R., Brandao, R.L., Kalapothakis, E., Castro, I.M. Expression and characterization of LTx2, a neurotoxin from Lasiodora sp. effecting on calcium channels. Peptides 2008, 29, 1505-1513.
188. Norton, R.S., Pallaghy, P.K. The cystine knot structure of ion channel toxins and related polypeptides. Toxicon 1998, 36, 1573-1583.
189. Schalle, J., Kampfer, U., Schurch, S., Kuhn-Nentwig, L., Haeberli, S., Nentwig, W. CSTX-9, a toxic peptide from the spider Cupiennius salei: amino acid sequence, disulphide bridge pattern and comparison with other spider toxins containing the cystine knot structure. Cell Mol. Life Sci. 2001, 58, 1538-1545.
190. Mouhat, S., Jouirou, B., Mosbah, A., De Waard, M., Sabatier, J.M. Diversity of folds in animal toxins acting on ion channels. Biochem. J. 2004, 378, 717-726.
191. Corzo, G., Escoubas, P. Pharmacologically active spider peptide toxins. Cell Mol. Life Sci. 2003, 60, 2409-2426.
192. Corzo, G., Escoubas, P., Stankiewicz, M., Pelhate, M., Kristensen, C.P., Nakajima, T. Isolation, synthesis and pharmacological characterization of δ-palutoxins IT, novel insecticidal toxins from the spider Paracoelotes luctuosus (Amaurobiidae). Eur. J. Biochem. 2000, 267, 5783-5795.
193. Tedford, H.W., Sollod, B.L., Maggio, F., King, G.F. Australian funnel-web spiders: master insecticide chemists. Toxicon 2004, 43, 601-618.
194. Black, B.C., Brennam, L.A., Dierks, P.M., Gard, I.E. Commercialization of baculoviral insecticides. In The Baculoviruses (Miller, Lois). In The Viruses, Plenum Press: New York, NY, USA, 1997, pp. 341-347.
195. Neurath H. Proteolytic processing and physiological regulation. Trends Biochem. Sci. 1989, 14, 268-271.
196. Otlewski, J., Krowarsch, D., Apostoluk, W. Protein inhibitors of serine proteinases. Acta Biochim. Pol. 1999, 46, 531-565.
197. Rimphanitchayakit, V., Tassanakajon, A. Structure and function of invertebrate Kazal type serine proteinase inhibitors. Dev. Comp. Immunol. 2010, 34, 377-386.
198. Laskowski, M., Jr., Kato, I. Protein inhibitors of proteinases. Annu. Rev. Biochem. 1980, 49, 593-626.
199. Krowarsch, D., Cierpicki, T., Jelen, F., Otlewski, J. Canonical protein inhibitors of serine proteases. Cell Mol. Life Sci. 2003, 60, 2427-2444.
200. Irving, J.A., Pike, R.N., Lesk, A.M., Whisstock, J.C. Phylogeny of the serpin superfamily: implications of patterns of amino acid conservation for structure and function. Genome Res. 2000, 10, 1845-1864.
201. Law, R.H., Zhang, Q., McGowan, S., Buckle, A.M., Silverman, G.A., Wong, W., Rosado, C.J., Langendorf, C.G., Pike, R.N., Bird, P.I., Whisstock, J.C. An overview of the serpin superfamily. Genome Biol. 2006, 7, 216.
202. Takahashi, H., Iwanaga, S., Suzuki, T. Distribution of proteinase inhibitors in snake venoms. Toxicon 1974, 12, 193-197.
203. Shafqat, J., Beg, O.U., Yin, S.J., Zaidi, Z.H., Jornvall, H. Primary structure and functional properties of cobra (Naja naja naja) venom Kunitz-type trypsin inhibitor. Eur. J. Biochem. 1990, 194, 337-341.
204. Shafqat, J., Zaidi, Z.H., Jornvall, H. Purification and characterization of a chymotrypsin Kunitz inhibitor type of polypeptide from the venom of cobra (Naja naja naja). FEBS Lett. 1990, 275, 6-8.
205. Chang, L., Chung, C., Huang, H.B., Lin, S. Purification and characterization of a chymotrypsin inhibitor from the venom of Ophiophagus hannah (King Cobra). Biochem. Biophys. Res. Commun. 2001, 283, 862-867.
206. Chen, C., Hsu, C.H., Su, N.Y., Lin, Y.C., Chiou, S.H., Wu, S.H. Solution structure of a Kunitz-type chymotrypsin inhibitor isolated from the elapid snake Bungarus fasciatus. J. Biol. Chem. 2001, 276, 45079-45087.
207. Lu, X.Z., Zou, Y.G., Yin, X.M., Chen, W.T., Zhang, C.P. Expression of MMP1 mRNA in oral squamous cell carcinoma and paired normal tissues. Nan Fang Yi Ke Da Xue Xue Bao 2008, 28, 1362-1364.
208. Zhou, X.D., Jin, Y., Lu, Q.M., Li, D.S., Zhu, S.W., Wang, W.Y., Xiong, Y.L. Purification, characterization and primary structure of a chymotrypsin inhibitor from Naja atra venom. Comp. Biochem. Physiol. B. Biochem. Mol. Biol. 2004, 137, 219-224.
209. He, D., Natarajan, V., Stern, R., Gorshkova, I.A., Solway, J., Spannhake, E.W., Zhao, Y. Lysophosphatidic acid-induced trans activation of epidermal growth factor receptor regulates cyclo-oxygenase-2 expression and prostaglandin E(2) release via C/EBPbeta in human bronchial epithelial cells. Biochem. J. 2008, 412, 153-162.
210. Millers, E.K., Trabi, M., Masci, P.P., Lavin, M.F., de Jersey, J., Guddat, L.W., Crystal structure of textilinin-1, a Kunitz-type serine protease inhibitor from the venom of the Australian common brown snake (Pseudonaja textilis). FEBS J. 2009, 276, 3163-3175.
211. Flight, S.M., Johnson, L.A., Trabi, M., Gaffney, P., Lavin, M., de Jersey, J., Masci, P. Comparison of textilinin-1 with aprotinin as serine protease inhibitors and as antifibrinolytic agents. Pathophysiol. Haemost. Thromb. 2005, 34, 188-193.
212. Flight, S.M., Johnson, L.A., Du, Q.S., Warner, R.L., Trabi, M., Gaffney, P.J., Lavin, M.F., de Jersey, J., Masci, P.P. Textilinin-1, an alternative anti-bleeding agent to aprotinin: Importance of plasmin inhibition in controlling blood loss. Br. J. Haematol. 2009, 145, 207-211.
213. Zhao, Y., Jin, Y., Wei, S.S., Lee, W.H., Zhang, Y. Purification and characterization of an irreversible serine protease inhibitor from skin secretions of Bufo andrewsi. Toxicon 2005, 46, 635-640.
214. Yuan, C.H., He, Q.Y., Peng, K., Diao, J.B., Jiang, L.P., Tang, X., Liang, S.P. Discovery of a distinct superfamily of Kunitz-type toxin (KTT) from tarantulas. PLoS One 2008, 3, e3414.
215. Duarte, M.M., Montes De Oca, H., Diniz, C.R., Fortes-Dias, C.L. Primary culture of venom gland cells from the South American rattlesnake (Crotalus durissus terrificus). Toxicon 1999, 37, 1673-1682.
216. Yamanouye, N., Kerchove, C.M., Moura-da-Silva, A.M., Carneiro, S.M., Markus, R.P. Long-term primary culture of secretory cells of Bothrops jararaca venom gland for venom production in vitro. Nat. Protocols 2007, 1, 2763-2766.
217. Silva, L.M., Lages, C.P., Venuto, T., Lima, R.M., Diniz, M.V., Valentim, C.L.L., Baba, E.H., Pimenta, P.F.P., Fortes-Dias, C.L. Primary culture of venom glands from the Brazilian armed spider, Phoneutria nigriventer (Araneae, Ctenidae). Toxicon 2008, 51, 428-434.
218. Domingos, M.O., Barbaro, K.C., Tynan, W., Penny, J., Lewis, D.J., New, R.R. Influence of sphingomyelin and TNF-alpha release on lethality and local inflammatory reaction induced by Loxosceles gaucho spider venom in mice. Toxicon 2003, 42, 471-479.
219. Barbaro, K.C., Lira, M.S., Araujo, C.A., Pareja-Santos, A., Tavora, B.C., Prezotto-Neto, J.P., Kimura, L.F., Lima, C., Lopes-Ferreira, M., Santoro, M.L. Inflammatory mediators generated at the site of inoculation of Loxosceles gaucho spider venom. Toxicon 2010, 56, 972-979.
220. Burgess, R.R., Richard, R.B., Murray, P.D. Refolding Solubilized Inclusion Body Proteins. In Methods in Enzymology, Academic Press: Salt Lake City, UT, USA, 2009, Volume 463, Chapter. 17, pp. 259-282.
221. Daly, R., Hearn, M.T. Expression of heterologous proteins in Pichia pastoris: a useful experimental tool in protein engineering and production. J. Mol. Recognit. 2005, 18, 119-138.
222. Benting, J., Lecat, S., Zacchetti, D., Simons, K. Protein Expression in Drosophila Schneider Cells. Anal. Biochem. 2000, 278, 59-68.
223. Rohrmann, G.F. Baculovirus Molecular Biology, European Molecular Biology Organization: Corvallis, OR, USA, 2008.
224. Wurm, F.M. Production of recombinant protein therapeutics in cultivated mammalian cells. Nat. Biotech. 2004, 22, 1393-1398.
225. Escoubas, P., Sollod, B., King, G.F. Venom landscapes: Mining the complexity of spider venoms via a combined cDNA and mass spectrometric approach. Toxicon 2006, 47, 650-663.
226. Murakami, M.T., Fernandes-Pedrosa, M.F., Tambourgi, D. V., Arni, R.K. Structural basis for metal ion coordination and the catalytic mechanism of sphingomyelinases D. J. Biol. Chem. 2005, 280, 13658-13664.